Physician profile
Heidi Busch
NPI 1467415174
$2,654.63
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.66 · 2020: $22.32 · 2021: $19.92 · 2022: $347 · 2023: $1,238 · 2024: $960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,160 · Food and Beverage: $37.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,160.00 |
| Food and Beverage | $37.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $2,160.00 | 2023-2024 | Venacure 1470 Pro |
| Lilly USA, LLC | $141.78 | 2020-2022 | |
| Abbvie INC. | $86.07 | 2022 | |
| Genzyme Corporation | $73.09 | 2022-2023 | |
| Leo Pharma INC. | $42.34 | 2019-2022 | |
| Pfizer INC. | $26.93 | 2022 | |
| Incyte Corporation | $23.94 | 2022 | |
| Pierre Fabre Pharmaceuticals, INC. | $19.92 | 2021 | |
| Galderma Laboratories, L.P. | $18.93 | 2019 | |
| Allergan, INC. | $17.83 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.09 | 2019 | |
| Dermavant Sciences, INC. | $14.84 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Busch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.